Title : Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer.

Pub. Date : 2018 Jul 2

PMID : 29787277






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We employ dual drugs, ZD6474, and epigallocatechin gallate (EGCG) that inhibit EGFR2, VEGFR2, and Akt signaling pathways since changes in these signaling pathways confer tamoxifen resistance in MCF 7 and T-47D cells. vandetanib AKT serine/threonine kinase 1 Homo sapiens